Glp-1 agonists

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Celexa

Full Member
7+ Year Member
Joined
Oct 15, 2017
Messages
833
Reaction score
2,493
Articles about using ozempic etc for weight loss have been all over the popular press. Has anyone had a patient using a glp-1 agonist inappropriately as part of eating disordered behaviors? I figure it's only a matter of time but I haven't come accross it yet.

Members don't see this ad.
 
Articles about using ozempic etc for weight loss have been all over the popular press. Has anyone had a patient using a glp-1 agonist inappropriately as part of eating disordered behaviors? I figure it's only a matter of time but I haven't come accross it yet.
Yes, yes, and yes. Already to the point that the AAP is potentially recommending doctors give these medications to children and family's that want them in place of actual treatment for binge eating disorder (I've already had 1 case personally). I am sure folks with AAN will be using these sooner rather than later. I would sincerely hope that anyone who can prescribe the medication is not giving it to someone with a normal A1C and normal to low body weight but I'm prepared to be disappointed.
 
Yes, yes, and yes. Already to the point that the AAP is potentially recommending doctors give these medications to children and family's that want them in place of actual treatment for binge eating disorder (I've already had 1 case personally). I am sure folks with AAN will be using these sooner rather than later. I would sincerely hope that anyone who can prescribe the medication is not giving it to someone with a normal A1C and normal to low body weight but I'm prepared to be disappointed.
You're seeing people give it for binge eating specifically, without a corresponding medical diagnosis of obesity or diabetes? I'm shocked an insurance company would cover it for that.

It seems grossly premature to me to prescribe these meds for binge eating outside of a high quality RCT in a well defined population with low comorbidity.

I'm also wondering if pts are going to start getting the med without a prescription through black market routes. Which also feels inevitable.
 
Members don't see this ad :)
You're seeing people give it for binge eating specifically, without a corresponding medical diagnosis of obesity or diabetes? I'm shocked an insurance company would cover it for that.

It seems grossly premature to me to prescribe these meds for binge eating outside of a high quality RCT in a well defined population with low comorbidity.

I'm also wondering if pts are going to start getting the med without a prescription through black market routes. Which also feels inevitable.
Yes just for obesity (no DM or preDM) with an underlying binge eating disorder that family did not want to support pt in getting real treatment for. There's huge uproar from the ED community around the very recent AAP guidelines recommending treatment of obesity with these medications. Like Vyvanse, even if the medication is approved, it will suppress appetite without addressing the reasons behind the binge eating or learning to structure a day to not engage with binge eating behaviors.

People are already getting the medication from "weight loss clinics", which can be any prescriber setting up a cash shop with any training in any area of medicine.
 
Yes just for obesity (no DM or preDM) with an underlying binge eating disorder that family did not want to support pt in getting real treatment for. There's huge uproar from the ED community around the very recent AAP guidelines recommending treatment of obesity with these medications.

What's the uproar exactly? The policy statement doesn't seem that controversial considering the efficacy of these medications for adolescents with obesity and the continued recommendations for behavioral therapy as first line.
  • Comprehensive obesity treatment may include nutrition support, physical activity treatment, behavioral therapy, pharmacotherapy, and metabolic and bariatric surgery.
  • Intensive health behavior and lifestyle treatment (IHBLT), while challenging to deliver and not universally available, is the most effective known behavioral treatment for child obesity. The most effective treatments include 26 or more hours of face-to-face, family-based, multicomponent treatment over a 3- to 12-month period.
  • Evidence-based treatment delivered by trained health care professionals with active parent or caregiver involvement has no evidence of harm and can result in less disordered eating.
  • Physicians should offer adolescents ages 12 years and older with obesity weight loss pharmacotherapy, according to medication indications, risks, and benefits, as an adjunct to health behavior and lifestyle treatment.
  • Teens age 13 and older with severe obesity (BMI ≥120% of the 95th percentile for age and sex) should be evaluated for metabolic and bariatric surgery.
 
I've prescribed WeGovy a few times with a structured regimen of diet (nutritionist referral, but not required) and exercise (personal trainer, but not required), where they have to have tried it for 6 months without getting an appreciable decrease in % body weight, only to those with BMI of over 30, but mostly in those with BMI over 40. One of them does have binge eating disorder dx that is responding very well to Vyvanse+CBT for BED and hasn't binged in several months, but weight is still tough to come down. I go through all of the weight loss medication options and options for bariatric surgery (especially to those with BMI over 40) as well. I have yet to prescribe it for anyone under 18.
 
I think it’d be tough to abuse. Those with anorexia don’t usually complain hunger is what’s stopping them. Those with bulimia (or BED) can’t really binge on these without feeling miserable and getting gastroparetic, nor can they work out excessively given the lower energy.

I’m sure there’s the rare individual with binge eating disorder and a low BMI but I am much more comfortable, and would argue, it’s safer to start someone with BED on a GLP1 rather than a stimulant. Insurance will only cover for BMI 27 + comorbidity or with a BMI of 30.

There is a huge black market for the compounded stuff. That’s what I’m more worried about. But if it stops your stereotypical overweight but not obese person from using crash diets, stimulants, nicotine, or cardiotoxic supplements, there may be some harm reduction benefits.
 
I'm planning on getting obesity boarded (pretty easy through CME pathway) so I can prescribe glp-1 agonists. I know some psychiatrists who do already but I feel it's more defensible from a medicolegal standpoint to argue that it's within my scope if I'm boarded in obesity medicine.

Anecdotally, patients that I have with BED or just disordered eating habits in general who have gotten started on wegovy or mounjaro have done amazing. Tbh, I've never had good success with vyvanse for BED.

Given the MOA of these medications, I'm not sure it would actually be desirable for people with anorexia nervosa. These aren't magic medications that cause people to lose weight. The mechanism of actions are several but the main ones are: increased satiety (causing you to eat less in a meal), prolonged gastric emptying (less urge to snack between meals), and increased sugar sensitivity (less urge to eat sugary foods). People with anorexia nervosa are not going to find any of those mechanisms to be of much help to lose weight...they're already not eating to satiety, not snacking between meals, and not eating sugary food. Something like vyvanse is actually *more* abusable for an eating disordered patient than glp-1 agonists.
 
I'm planning on getting obesity boarded (pretty easy through CME pathway) so I can prescribe glp-1 agonists. I know some psychiatrists who do already but I feel it's more defensible from a medicolegal standpoint to argue that it's within my scope if I'm boarded in obesity medicine.

Anecdotally, patients that I have with BED or just disordered eating habits in general who have gotten started on wegovy or mounjaro have done amazing. Tbh, I've never had good success with vyvanse for BED.

Given the MOA of these medications, I'm not sure it would actually be desirable for people with anorexia nervosa. These aren't magic medications that cause people to lose weight. The mechanism of actions are several but the main ones are: increased satiety (causing you to eat less in a meal), prolonged gastric emptying (less urge to snack between meals), and increased sugar sensitivity (less urge to eat sugary foods). People with anorexia nervosa are not going to find any of those mechanisms to be of much help to lose weight...they're already not eating to satiety, not snacking between meals, and not eating sugary food. Something like vyvanse is actually *more* abusable for an eating disordered patient than glp-1 agonists.
How does one get boarded in obesity?
 
CME pathway is pretty straightforward. You need 60 obesity CME's to be eligible. The official obesity medicine board review course is 60 CME's so basically just take the board review course and then the board exam. From what I understand, the boards aren't too difficult. It's probably not necessary tbh, but it's mostly so I'm not accused of practicing outside the scope of a psychiatrist.
 
CME pathway is pretty straightforward. You need 60 obesity CME's to be eligible. The official obesity medicine board review course is 60 CME's so basically just take the board review course and then the board exam. From what I understand, the boards aren't too difficult. It's probably not necessary tbh, but it's mostly so I'm not accused of practicing outside the scope of a psychiatrist.
obesity, so often rooted in cognitive and behavioral maladaptation is in the psychiatrist's wheelhouse more so than many other docs.
 
How does one get boarded in obesity?

I might go for this too now before they make it a full fellowship or increase requirements to make it much harder to get the BC.
 
Very interesting discussion so far. I am more convinced by the arguments that these medications may be very helpful in binge eating than I am the arguments that they are unlikely to be abused by patients with restrictive type eating disorders. Patients with severe restrictive eating disorders are the furthest thing from rational and pursue illogical and dangerous means of weight loss/prevention of weight gain all the time. I'm not sure anything more than it being an available medication for weight loss matters on that level. And you can get dangerous physiologic sequelae of rapid weight loss while still at a normal or overweight bmi, so there are certainly patients with restrictive and purging eating behaviors who won't raise red flags to most physicians.
 
Members don't see this ad :)
The president should nationalize glp1-agonists citing obesity as a national emergency.
 
Very interesting discussion so far. I am more convinced by the arguments that these medications may be very helpful in binge eating than I am the arguments that they are unlikely to be abused by patients with restrictive type eating disorders. Patients with severe restrictive eating disorders are the furthest thing from rational and pursue illogical and dangerous means of weight loss/prevention of weight gain all the time. I'm not sure anything more than it being an available medication for weight loss matters on that level. And you can get dangerous physiologic sequelae of rapid weight loss while still at a normal or overweight bmi, so there are certainly patients with restrictive and purging eating behaviors who won't raise red flags to most physicians.
Absolutely, atypical anorexia nervosa is just as dangerous as anorexia nervosa from an acute death scenario and the medical establishment is often encouraging this type of weight loss rather than raising red flags. It's also much easier to come by non-controlled medications than Vyvanse.

I think prescribing these medications to patients with eating disorders as a harm-reduction strategy is a very dangerous pathway. It's like trying to give Xanax 2mg 6x daily to someone to replace them drinking a liter of vodka daily. People need specialized eating disorder treatment when these are identified, not an injection that might mask a symptom without addressing any underlying condition and require routine injections ad infinity to maintain the benefit. If anything, I expect patients with BED that are managed with Glp-1 a's to do worse when they come off than had they never been on in the first place as all they have learned is to manually change their hunger/satiety using medication rather than changing their enviornment, cognitions, or lifestyle.
 
I think all of this is fine to speculate, but I want to see these hypotheses tested in an academic setting in a rigorous manner. I don't usually use anything off label unless there's some evidence to do so.

Looks like there are some pilot studies, but none with semaglutide.




And a review:

That review says there are case reports of using it successfully in hyperphagia associated with Prader-Wili syndorme and those with hypothalamic obesity. I'd probably be more keen in using it in the intellectual disability, genetic abnormality patient population, especially those who are minimally verbal and can be aggressive due to their food cravings that I see as a CAP.

Another thing I wonder is about whether it would be useful for antipsychotic-induced weight gain when metformin and topiramate don't work.
 
That review says there are case reports of using it successfully in hyperphagia associated with Prader-Wili syndorme and those with hypothalamic obesity. I'd probably be more keen in using it in the intellectual disability, genetic abnormality patient population, especially those who are minimally verbal and can be aggressive due to their food cravings that I see as a CAP.

Another thing I wonder is about whether it would be useful for antipsychotic-induced weight gain when metformin and topiramate don't work.
I am most excited about these medications for exactly those populations. Anyone in the ID/severe ASD w/ hyperphagia or genetic disorders w/ hyperphagia and particularly when using antipsychotics where we often need appetite stimulating meds to keep kids/family's safe.

Even just for failed Metformin on atypical it makes a lot of sense to me. These are an ideal usage of this intervention to counteract a side-effect or assist with a genetic condition rather than trying to help someone not do the therapy needed to treat BED/BN.
 
Last edited:
The data is definitely there, just needs someone to sift through it, analyze, and publish. I've had multiple patients with binge eating disorder get started on GLP-1 agonists. Not by me, but by their PCP or endocrinologist. Most people with binge eating disorder will meet the criteria for GLP-1 agonists based on BMI.
 
The data is definitely there, just needs someone to sift through it, analyze, and publish. I've had multiple patients with binge eating disorder get started on GLP-1 agonists. Not by me, but by their PCP or endocrinologist. Most people with binge eating disorder will meet the criteria for GLP-1 agonists based on BMI.
The question is not just does the patient lose weight or have less binge eating episodes, I have little doubt that will be the case.

The question is long-term what is in the best interest of the patient, what are the long-term side effects of lifelong GLP-1a's and what happens to people who need to stop taking the medication.

This is Benzos for anxiety all over again. Yes you can lower reports of anxiety with Klonapin 2mg TID, congratulations. There's much more to the story than that.
 
The question is not just does the patient lose weight or have less binge eating episodes, I have little doubt that will be the case.

The question is long-term what is in the best interest of the patient, what are the long-term side effects of lifelong GLP-1a's and what happens to people who need to stop taking the medication.

This is Benzos for anxiety all over again. Yes you can lower reports of anxiety with Klonapin 2mg TID, congratulations. There's much more to the story than that.

I don't understand the moral outrage here. This is like saying we shouldn't be providing anti-hypertensive treatment to people who are unwilling to follow behavioral modification/lifestyle modification. Unless you have some data showing that GLP-1 agonists result in actual habituation requiring higher doses with chronic use and life threatening withdrawal symptoms like benzodiazepines.

I guess unless you're talking about just for binge eating disorder here with a subthreshold BMI? But you seemed also upset that AAP included it in general guidelines for obesity treatment for adolescents.
 
Last edited:
I don't understand the moral outrage here. This is like saying we shouldn't be providing anti-hypertensive treatment to people who are unwilling to follow behavioral modification/lifestyle modification. Unless you have some data showing that GLP-1 agonists result in actual habituation requiring higher doses with chronic use and life threatening withdrawal symptoms like benzodiazepines.
There's no morality to the outrage and I don't have any expectation of needing higher dosages. I do think as a field we run significant risks when we use medication in place of psychotherapy/behavioral interventions and I have already seen this being the case in the very short amount of time these medications have been around. This is being labeled the miracle weight loss drug the world has been waiting for and this carries with it significant impact, particularly in the case for eating disorder patients (which my practice specializes in).

It's not just benzos that this reminds me of. At my last OP practice, I routinely saw patient's with social anxiety started on an SSRI by PCPs, never get into therapy, bomb out of school and then come to me a year after switching to online school to figure out what's next in the treatment of their social anxiety. The answer to most problems we deal with is not throw a pill/injection at it because the data supports its use and then walk away and I know this is occurring and will continue to occur with GLP-1a's in the ED space. There is going to be a lot of appropriate and good use for these medications and there is also going to be a lot of inappropriate use of them.
 
This is interesting, but the drug ultimately makes you less hungry, right? I had conceptualized it like a lap band in a pill. As such, I don't know exactly if it will be helpful for binge eating. It might give them more of a feedback to stop? In terms of anorexia, I'm sure someone will try to abuse it, but like others said, hunger is already deeply broken in anorexia. It certainly isn't going to be helpful, but I'm betting it would be much less harmful than something OTC like laxatives or Alli. In terms of age, it's specifically studied for 12 and up. It's rare to get something studied in kids and we should use something that has been when we have the opportunity. As with nearly everything else, it should be done with talk therapy. The issue with talk therapy is not with the patient, it's with the payors and availability of providers. The question is never should we do this with or without talk therapy. Of course with talk therapy. The real question ends up being should we do this or nothing at all. Also, this is not benzos or opiates. We have to make a pretty firm distinction between drugs the rats will press the lever for and those they won't.
 
Last edited:
The question is not just does the patient lose weight or have less binge eating episodes, I have little doubt that will be the case.

The question is long-term what is in the best interest of the patient, what are the long-term side effects of lifelong GLP-1a's and what happens to people who need to stop taking the medication.

This is Benzos for anxiety all over again. Yes you can lower reports of anxiety with Klonapin 2mg TID, congratulations. There's much more to the story than that.
I share your concern about these meds in pta with restrictive eating disorders, but in patients with pure binge eating and no restriction or purging, why do you think the analogy is to benzos and not to MAT to opioid use disorder? The latter strikes me as more apt. Weve lost a lot of lives and continue to do so by underutilizing MAT. MAT doesnt remove the need for psychosocial interventions, but it can provide pts with very needed cognitive space to engage in them.
 
There's no morality to the outrage and I don't have any expectation of needing higher dosages. I do think as a field we run significant risks when we use medication in place of psychotherapy/behavioral interventions and I have already seen this being the case in the very short amount of time these medications have been around. This is being labeled the miracle weight loss drug the world has been waiting for and this carries with it significant impact, particularly in the case for eating disorder patients (which my practice specializes in).

It's not just benzos that this reminds me of. At my last OP practice, I routinely saw patient's with social anxiety started on an SSRI by PCPs, never get into therapy, bomb out of school and then come to me a year after switching to online school to figure out what's next in the treatment of their social anxiety. The answer to most problems we deal with is not throw a pill/injection at it because the data supports its use and then walk away and I know this is occurring and will continue to occur with GLP-1a's in the ED space. There is going to be a lot of appropriate and good use for these medications and there is also going to be a lot of inappropriate use of them.

So what's the problem with the AAP position statement then? That someone could prescribe these medications without the patient engaging in behavioral programs or psychotherapy? What about in the middle of nowhere america where you pretty much can't find a decent therapist to see a kid and everyone's on Medicaid? That's a huge chunk of your obese teen population.

I think there's also the issue of selection bias. When you saw the above patients you're referring to, you're seeing a specific referral population of patient who did not improve with the SSRI alone. They are then coming to a psychiatrist for a reason....they didn't get better. There are certainly patients who you never saw who improved on SSRIs alone or just needed the SSRI for a time period and then came off it or get into therapy later after being on the SSRI for a while.

It's again like a cardiologist lamenting that PCPs start all these people on anti-hypertensives without making sure the people adhered to behavioral recommendations and then some of them come to their office because their blood pressure didn't get better on the ACEi without taking into account all the people who never needed to end up seeing cardiology to begin with.
 
I share your concern about these meds in pta with restrictive eating disorders, but in patients with pure binge eating and no restriction or purging, why do you think the analogy is to benzos and not to MAT to opioid use disorder? The latter strikes me as more apt. Weve lost a lot of lives and continue to do so by underutilizing MAT. MAT doesnt remove the need for psychosocial interventions, but it can provide pts with very needed cognitive space to engage in them.
Because pure binge eating disorder is not a disorder of addiction circuitry. It's a problem of eating to excess as a maladaptive coping skill or as part of restrict/binge cycles that relate to underlying body image/self-esteem rooted core problems. Food or sugar addiction you can certainly argue is an addiction circuitry problem, I could conceive of this being potentially useful in those patients. I'd also be open to their use as part of a comprehensive treatment program for BED if they were used in a time-limited manner if this was shown to actually be more effective than the program without the GLP-1a.
 
The question is not just does the patient lose weight or have less binge eating episodes, I have little doubt that will be the case.

The question is long-term what is in the best interest of the patient, what are the long-term side effects of lifelong GLP-1a's and what happens to people who need to stop taking the medication.

This is Benzos for anxiety all over again. Yes you can lower reports of anxiety with Klonapin 2mg TID, congratulations. There's much more to the story than that.
Keep in mind that the first GLP-1 hit the market 18 years ago. Not exactly life long, but pretty good long term data so far.
 
So what's the problem with the AAP position statement then? That someone could prescribe these medications without the patient engaging in behavioral programs or psychotherapy? What about in the middle of nowhere america where you pretty much can't find a decent therapist to see a kid and everyone's on Medicaid? That's a huge chunk of your obese teen population.

I think there's also the issue of selection bias. When you saw the above patients you're referring to, you're seeing a specific referral population of patient who did not improve with the SSRI alone. They are then coming to a psychiatrist for a reason....they didn't get better. There are certainly patients who you never saw who improved on SSRIs alone or just needed the SSRI for a time period and then came off it or get into therapy later after being on the SSRI for a while.

It's again like a cardiologist lamenting that PCPs start all these people on anti-hypertensives without making sure the people adhered to behavioral recommendations and then some of them come to their office because their blood pressure didn't get better on the ACEi without taking into account all the people who never needed to end up seeing cardiology to begin with.
The problem is a focus on weight alone as a measure of health, about telling kids that you should be considering daily to weekly injections because of this or even bariatric surgery and how this can directly do harm by promoting fat phobia/weight stigma which in turn promote eating disorders.

The subsidy of sugar, ultraprocessed foods, income inequality, etc are all huge underpinnings to the raise in adolescent weight, we are not finding our way out of this problem with more GLP-1a's or lap bands in kids.

Here are some mainstream news articles that have arisen to give you people's opinion that are more experienced than I:
 
The problem is a focus on weight alone as a measure of health, about telling kids that you should be considering daily to weekly injections because of this or even bariatric surgery and how this can directly do harm by promoting fat phobia/weight stigma which in turn promote eating disorders.

The subsidy of sugar, ultraprocessed foods, income inequality, etc are all huge underpinnings to the raise in adolescent weight, we are not finding our way out of this problem with more GLP-1a's or lap bands in kids.

Here are some mainstream news articles that have arisen to give you people's opinion that are more experienced than I:
Are you kidding me?

From the NYT article: "But the guidelines are rooted in a premise that should have been rejected long ago: that weight loss is the best path to health and happiness."

Utter BS. We know that obesity, even in children, is not healthy. Full stop. Anyone suggesting otherwise is just wrong.

Now you can very reasonably argue that this approach can cause issues with eating disorder but I'm not sure its wise to not aggressively treat obese children because of that.
 
The problem is a focus on weight alone as a measure of health, about telling kids that you should be considering daily to weekly injections because of this or even bariatric surgery and how this can directly do harm by promoting fat phobia/weight stigma which in turn promote eating disorders.

The subsidy of sugar, ultraprocessed foods, income inequality, etc are all huge underpinnings to the raise in adolescent weight, we are not finding our way out of this problem with more GLP-1a's or lap bands in kids.

Here are some mainstream news articles that have arisen to give you people's opinion that are more experienced than I:

Are you seriously responding to a consensus statement and clinical practice guidelines from the AAP with a NYT opinion piece by a freelance journalist? Or the clinicaladvisor piece written by a couple of "medical journalists"? These are people who are "more experienced" than you and apparently the AAP?

WTF I hope not. I definitely know they're not more experienced than me.
 
Are you seriously responding to a consensus statement and clinical practice guidelines from the AAP with a NYT opinion piece by a freelance journalist? Or the clinicaladvisor piece written by a couple of "medical journalists"? These are people who are "more experienced" than you and apparently the AAP?

WTF I hope not. I definitely know they're not more experienced than me.
That was one of the top 3 google links that came up, I see that you are referencing that and not the ones that are posted by physicians and ED organizations. Since you seem to be very knowledgeable about the space, I am sure you aware ERC is one of the largest ED treatment centers in the country and their leadership includes some of the top folks in the field.

It seems like this area provokes something with folks, I kind of understand that it can appear that people in the ED space are somehow wanting to keep kids fat which couldn't be further from the truth. To say that the AAP guidelines are controversial is irrefutable, essentially every eating disorder organization in the country has come out with critique of the most recent guidelines. Their own members in adolescent medicine have provided critique/criticism of the guidelines. If you think all of those docs are wrong and you're right, that's fine to take that stance but this is clearly not some cut and dry issue.
 
obesity, so often rooted in cognitive and behavioral maladaptation is in the psychiatrist's wheelhouse more so than many other docs.

But by this logic, PCPs should refer all obese patients to psych. Why stop there? Almost all patient issues are related to maladaptive behaviors and thoughts. Send us your HTN, DM, HFpEF, CKD, smoking, etc. patients. Surgeons and some primary medical teams already recognize our wheelhouse and freely consult for: crying, not listening, needs someone to talk to.
 
This is Benzos for anxiety all over again. Yes you can lower reports of anxiety with Klonapin 2mg TID, congratulations. There's much more to the story than that.

These aren’t meds that lead to dependence. It’s like Prozac for anxiety all over again. I wish all my patients with anxiety would regularly work with a therapist and learn the behavioral skills that help. Some still need Prozac despite this. Most aren’t willing or able to put in the work.

I hear you on and fully agree with wanting more long term safety data
 
But by this logic, PCPs should refer all obese patients to psych. Why stop there? Almost all patient issues are related to maladaptive behaviors and thoughts. Send us your HTN, DM, HFpEF, CKD, smoking, etc. patients. Surgeons and some primary medical teams already recognize our wheelhouse and freely consult for: crying, not listening, needs someone to talk to.
Except prior to ozempic, us PCPs had basically no good tools for obesity. We have lots of other tools for everything else you mentioned.
 
Agree with Clozareal-don't even go there with these meds unless the patient is significantly overweight. Also I've mentioned it before. I find it downright shocking that there's no eating disorder for someone who eats excessively not explainable by other phenomenon such as a TBI. I've encountered so many morbidly obese patients and to see there's no diagnosis that fits them despite that I see patterns with it even ones that have been showed in documentaries wow. It really goes to show you how biased we are. We'll diagnose someone with Anorexia but someone >300 lbs of weight who eats all day long we're not going to identify something's wrong with that person? We've had depression augmentation meds for decades but the one that gets the FDA approval that wasn't better than the generic stuff (Abilify) becomes the most prescribed med in America.

Getting back to the original question-I haven't had an Anorexic or Bulimic patient yet ask for a GLP-1 agonist but it's going to happen and is happening with other physicians. Any field of medicine is going to have the type of patient who is trying to take matters into their own hands, and not to blame it completely on them, add that patient to a doctor willing to enable the patient's problem. Michael Jackson is a great example of this with his dozens of plastic surgeries and the idiot doctor who gave him anything he wanted that eventually led to his death.
 
I have not had any ED patient ask for this.

I’m hoping it gets extended to MetS from AP use. I have had a SZ patient who has only been stable with X med but gets chronic slow weight gain and lipodystrophy ask for it. She’s got great insight, works/employed, exercises, eats reasonably… but she is just slowly slowly getting fatter and fatter. In ten years this is going to be a poly-metabolic disorder (DM + HTN most likely).

I wish I could get approval for these folks on chronic APs. Metformin doesn’t always cut it. Sad to watch it happen, especially when they are doing so well otherwise.
 
I think it’d be tough to abuse. Those with anorexia don’t usually complain hunger is what’s stopping them. Those with bulimia (or BED) can’t really binge on these without feeling miserable and getting gastroparetic, nor can they work out excessively given the lower energy.

I’m sure there’s the rare individual with binge eating disorder and a low BMI but I am much more comfortable, and would argue, it’s safer to start someone with BED on a GLP1 rather than a stimulant. Insurance will only cover for BMI 27 + comorbidity or with a BMI of 30.

There is a huge black market for the compounded stuff. That’s what I’m more worried about. But if it stops your stereotypical overweight but not obese person from using crash diets, stimulants, nicotine, or cardiotoxic supplements, there may be some harm reduction benefits.
I think my concern is some of the testimonials I've read, where people have lost the weight they planned to lose, look like they're clearly in the range of <20 or so BMI, and state they want to stay on it forever and they only eat a meal a day. We may unintentionally be manufacturing anorexics through pharmaceutical means. Really wish I could find the couple of articles I'd read on this, if you swapped it ozempic for anorexia, they were basically describing many of the same desires, eating patterns, and weight trajectories. As someone who has worked on 3 eating disorder services over the years, it set off mega red flags.
 
obesity, so often rooted in cognitive and behavioral maladaptation is in the psychiatrist's wheelhouse more so than many other docs.
I don't think the 20-30 minutes I can afford an outpatient once every 4-6 weeks is going to shake them out of their eating habits. A psychologist that can see them weekly, or a psychiatrist taking cash that can afford to spend the extra time, perhaps
 
That was one of the top 3 google links that came up, I see that you are referencing that and not the ones that are posted by physicians and ED organizations. Since you seem to be very knowledgeable about the space, I am sure you aware ERC is one of the largest ED treatment centers in the country and their leadership includes some of the top folks in the field.

It seems like this area provokes something with folks, I kind of understand that it can appear that people in the ED space are somehow wanting to keep kids fat which couldn't be further from the truth. To say that the AAP guidelines are controversial is irrefutable, essentially every eating disorder organization in the country has come out with critique of the most recent guidelines. Their own members in adolescent medicine have provided critique/criticism of the guidelines. If you think all of those docs are wrong and you're right, that's fine to take that stance but this is clearly not some cut and dry issue.

Nope I’m referencing all of them. Did you actually even read them?

1 is an opinion piece by some journalist whose claim to expertise is that she wrote a book called “Fat Talk” and randomly references cherry picked studies in the style of an opinion piece.

2 is again a piece written by a couple medical journalists that say that CEDO and ERC don’t like the guidelines and just throw them in the references. If you actually read the references, CEDO is super “anti obesity word” and literally puts “obesity” in quotes constantly while railing against the fact that anyone would consider even calling kids “obese” in the first place or use weight loss as a possible risk reduction strategy. There’s ridiculous statements on there like type 2 diabetes and heart disease aren’t linked to increased mortality rates in teens….which is a true statement but completely misses or intentionally obfuscates the point of treating those conditions early.
ERC is correct that kids should be screened for eating disorders if we’re addressing weight but also brings up the “healthy at any weight” idea.

3 is an NPR piece that’s much more balanced and actually includes replies from the AAP members addressing these concerns. They note that they addess many of these concerns within the actual guidelines which is true.

This is literally in the first section of the guidelines…have you actually read them?

“Understanding the underlying genetic, biological, environmental, and social determinants that pose risk for obesity is the bedrock of all evaluation and intervention. Allowing the family to have a safe space to understand and process the complexity of obesity and its chronicity requires tact, empathy, and humility. Achieving this goal enables the patient and family to gain the knowledge and understanding needed to recognize risk factors in their environment and behaviors, to honor cultural preferences, and to institute changes independently as well as under the guidance of a trusted and well-trained advocate—such as pediatricians and other PHCPs.”

I mean you could apply this same logic to our field. We SHOCKINGLY prescribe SSRIs to young children when instead we should be fixing underlying social, family and economic factors contributing to psychiatric conditions.
 
Last edited:
I have not had any ED patient ask for this.

I’m hoping it gets extended to MetS from AP use. I have had a SZ patient who has only been stable with X med but gets chronic slow weight gain and lipodystrophy ask for it. She’s got great insight, works/employed, exercises, eats reasonably… but she is just slowly slowly getting fatter and fatter. In ten years this is going to be a poly-metabolic disorder (DM + HTN most likely).

I wish I could get approval for these folks on chronic APs. Metformin doesn’t always cut it. Sad to watch it happen, especially when they are doing so well otherwise.
You'd probably be able to get it approved if they meet any of the metabolic syndrome criteria and a BMI of ≥ 27 and have tried 6 months of lifestyle/diet. It's probably more worthwhile to try topiramate after metformin for AP weight gain and if that doesn't work then try for a GLP-1 agonist.
 
I mean you could apply this same logic to our field. We SHOCKINGLY prescribe SSRIs to young children when instead we should be fixing underlying social, family and economic factors contributing to psychiatric conditions.
This is not the same at all. You don't go into your pediatrician's office and get diagnosed with or referred to treatment because of a number on scale (yes even high PHQ 9's). They are still looking for functional impairment to be started on an SSRI or referred to psych. If you come in with a BMI of 27 with normal vitals/blood workup, you are still being told that something is wrong with you. Who that conversation is with and how it is handled matters.

"Dieting and weight talk — comments about weight and weight loss, no matter who they're directed toward — are associated with higher risk of both obesity and eating disorders, and they can assign moral value to food, so try to avoid them."

I think it's very hard to argue that your doctor telling you to start metformin at age 12 for obesity without medical comorbidity is A) helpful in the long-term for overall health and B) not associated with causing harm. If you evidence to the contrary I would love to see it.
 
This is not the same at all. You don't go into your pediatrician's office and get diagnosed with or referred to treatment because of a number on scale (yes even high PHQ 9's). They are still looking for functional impairment to be started on an SSRI or referred to psych. If you come in with a BMI of 27 with normal vitals/blood workup, you are still being told that something is wrong with you. Who that conversation is with and how it is handled matters.

"Dieting and weight talk — comments about weight and weight loss, no matter who they're directed toward — are associated with higher risk of both obesity and eating disorders, and they can assign moral value to food, so try to avoid them."

I think it's very hard to argue that your doctor telling you to start metformin at age 12 for obesity without medical comorbidity is A) helpful in the long-term for overall health and B) not associated with causing harm. If you evidence to the contrary I would love to see it.

It's still not clear to me that you've actually read the guidelines cause it's pretty obvious from the guidelines they aren't suggesting pediatricians go "whoa your BMI is X number, guess we better start some meds right away!". This is pretty much the same caricature people make of child psychiatry overall so it's kind of sad you're even viewing it this way.

How is it "very hard to argue" that at all? That's begging the question if I ever saw it....if you have solid evidence that starting metformin at age 12 for obesity IS associated with causing more harm than benefit, I'd love to see that as well.
 
How is it "very hard to argue" that at all? That's begging the question if I ever saw it....if you have solid evidence that starting metformin at age 12 for obesity IS associated with causing more harm than benefit, I'd love to see that as well.
This is so logically inconsistent I don't know what to say, it feels very unlike you. This is THE treatment guidelines for children throughout the US. If you make sweeping guidelines that suggest talking to 12 year olds about weigh lose medications based on their weight number alone is to be recommended, one would hope that is based on significant studies, including longitudinal studies when we specifically know of risks associated with this. I have read the guidelines and the discussion of weight loss medication shows a dearth of these studies. This has nothing to do with "begging the question", it's a request for evidence to support controversial guidelines.
 
Agree with Clozareal-don't even go there with these meds unless the patient is significantly overweight. Also I've mentioned it before. I find it downright shocking that there's no eating disorder for someone who eats excessively not explainable by other phenomenon such as a TBI. I've encountered so many morbidly obese patients and to see there's no diagnosis that fits them despite that I see patterns with it even ones that have been showed in documentaries wow. It really goes to show you how biased we are. We'll diagnose someone with Anorexia but someone >300 lbs of weight who eats all day long we're not going to identify something's wrong with that person? We've had depression augmentation meds for decades but the one that gets the FDA approval that wasn't better than the generic stuff (Abilify) becomes the most prescribed med in America.

Getting back to the original question-I haven't had an Anorexic or Bulimic patient yet ask for a GLP-1 agonist but it's going to happen and is happening with other physicians. Any field of medicine is going to have the type of patient who is trying to take matters into their own hands, and not to blame it completely on them, add that patient to a doctor willing to enable the patient's problem. Michael Jackson is a great example of this with his dozens of plastic surgeries and the idiot doctor who gave him anything he wanted that eventually led to his death.
Many of these patients do have sugar addiction or binge eating. Some don't and instead use eating as a maladaptive coping strategy that does not meet criteria for either of those conditions in which case it should have a diagnosis like self-harm, I agree, but we typically don't have DSM diagnosis exclusively based on the maladaptive coping skill (just v codes).
 
This is so logically inconsistent I don't know what to say, it feels very unlike you. This is THE treatment guidelines for children throughout the US. If you make sweeping guidelines that suggest talking to 12 year olds about weigh lose medications based on their weight number alone is to be recommended, one would hope that is based on significant studies, including longitudinal studies when we specifically know of risks associated with this. I have read the guidelines and the discussion of weight loss medication shows a dearth of these studies. This has nothing to do with "begging the question", it's a request for evidence to support controversial guidelines.
I'm sorry, but where are you getting the impression that pediatricians are going around throwing metformin and GLP -1 agonists at 12 year olds whp have a BMI of 27 and are otherwise healthy without talking about lifestyle factors?

Because if that were to actually be happening, it could be bad. But we're not really talking in this thread about real situations, right? Just imaginary hypotheticals where the doctors are nothing but walking PEZ dispensers and the patients are incapable of hearing anything but the drug instructions?
 
I'm sorry, but where are you getting the impression that pediatricians are going around throwing metformin and GLP -1 agonists at 12 year olds whp have a BMI of 27 and are otherwise healthy without talking about lifestyle factors?

Because if that were to actually be happening, it could be bad. But we're not really talking in this thread about real situations, right? Just imaginary hypotheticals where the doctors are nothing but walking PEZ dispensers and the patients are incapable of hearing anything but the drug instructions?
That's the whole point. They are absolutely not doing that right now, I think most doctors who spend all day with kids can see the folly in that. When you then change the equation by adding it as a step of care in a treatment guideline, the whole purpose of that is to get said doctors to think about it.

If AACAP added a new guideline suggesting we consider Xanax in every 12 year old with school refusal (with the usual blah blah after behavioral interventions trialed), it sure wouldn't crop up overnight, but every fellowship should have every CAP reading all the guidelines we have and that certainly will impact prescription on some level, even if the effect is delayed by years.

I'm not trying to compare this tiny portion of the guidelines to global warming or some catastrophe, but I think it's very fair to have concerns around how we discuss medication for children that are obese with the pure goal of lowering their weight. We know there is harm associated with that, even if the specialty care of dealing with that harm is referred out to specialists.
 
This is a great discussion and has led me to briefly look over some data GLP-1 agonists in pediatric populations.

This study suggests that they are more effective for weight loss in those with obesity than those with diabetes alone. Makes sense that there would be a HgbA1c drop in those with prediabetes than obesity alone. They say that the effect size is comparable to adults, but these studies don't compare children to adults.

It looks like the odds for a teen of losing weight with a GLP-1 agonist is HUGE compared to placebo/lifestyle intervention alone. Interesting tidbit about semaglutide being associated with gallstones whereas no one in the placebo group had that.

Some pediatricians would rather prescribe medications than counsel on lifestyle because the majority of pediatrician visits are less than 20 minutes. It's really tough to get everything in during that time, especially for a teen who may already sensitive about body weight. However, I would hope that most would counsel on lifestyle interventions first, just as in mental health where if there is anxiety or depression, I hope they would counsel on lifestyle interventions first if there is no high severity or risk concerns.
 
This is a great discussion and has led me to briefly look over some data GLP-1 agonists in pediatric populations.

This study suggests that they are more effective for weight loss in those with obesity than those with diabetes alone. Makes sense that there would be a HgbA1c drop in those with prediabetes than obesity alone. They say that the effect size is comparable to adults, but these studies don't compare children to adults.

It looks like the odds for a teen of losing weight with a GLP-1 agonist is HUGE compared to placebo/lifestyle intervention alone. Interesting tidbit about semaglutide being associated with gallstones whereas no one in the placebo group had that.

Some pediatricians would rather prescribe medications than counsel on lifestyle because the majority of pediatrician visits are less than 20 minutes. It's really tough to get everything in during that time, especially for a teen who may already sensitive about body weight. However, I would hope that most would counsel on lifestyle interventions first, just as in mental health where if there is anxiety or depression, I hope they would counsel on lifestyle interventions first if there is no high severity or risk concerns.
Plus counseling on lifestyle isn’t effective
 
This is not the same at all. You don't go into your pediatrician's office and get diagnosed with or referred to treatment because of a number on scale (yes even high PHQ 9's). They are still looking for functional impairment to be started on an SSRI or referred to psych. If you come in with a BMI of 27 with normal vitals/blood workup, you are still being told that something is wrong with you. Who that conversation is with and how it is handled matters.

"Dieting and weight talk — comments about weight and weight loss, no matter who they're directed toward — are associated with higher risk of both obesity and eating disorders, and they can assign moral value to food, so try to avoid them."

I think it's very hard to argue that your doctor telling you to start metformin at age 12 for obesity without medical comorbidity is A) helpful in the long-term for overall health and B) not associated with causing harm. If you evidence to the contrary I would love to see it.
Eh, I disagree, personally. I think that lifestyle interventions should be a significant focus and that obesity is a major issue that is easier to interrupt in its earlier stages.


 
Top